Oxytocic Pharmaceuticals Market: Global Industry Analysis
and Opportunity Assessment 2016-2026
May 2017
Report Id : REP-GB-1445
Status : Jan-2017
Category : Healthcare, Pharmaceuticals & Medical Devices
©2015 Future Market Insights, All Rights Reserved
About
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities




Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage




Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
©2015 Future Market Insights, All Rights Reserved
2
Research Methodology (1/2)
Systematic Research Approach
1
Market profiling
2
Formulating discussion guide
3
Developing list of respondents
4
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
PMR formulates a detailed discussion
guide to conduct expert and industry
interviews
PMR develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
Data collection
PMR conducts interviews with industry
experts, industry players, distributors
and retailers
Data validation
Data is validated by triangulation
method, wherein secondary, primary
and PMR analysis contribute to the final
data
5
6
Data analysis
Insights
7
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
PMR delivers industry insights and
information in the required format
(PDF)
Data
Collection




Research &
Intelligence
Data Filter
& Analysis
Identifying key opinion leaders
Questionnaire design
In-depth interviews
Coverage across value chain
Actionable
Insights
A
Primary
Research






B
SOLUTION





Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
Primary Research #




Linkedin
Zoominfo
Salesforce
Avention
Business
Solution
Desk
Research
C
Key industry experts
Channel study
Developments
Market dynamics
Products
Conclusions
Company
Analysis
Secondary Research #




Company websites
Company annual
reports
White papers
Financial reports
Paid Publications#




Factiva
GBI
Genios
Meltwater
# includes sources of databases
©2015 Future Market Insights, All Rights Reserved
3
Europe Hospital Capacity Management Solutions Market
Synthetic Oxytocic Pharmaceuticals will Amass Nearly US$ 150 Million Revenues by 2026-end
Though synthetic oxytocin is chemically equivalent to naturally-occurring oxytocin, their pharmaceutical
functions for aiding women in labour are quite distinctive. Medical professionals from around the world
will continue to recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic
pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labour by IV
administration. More than 90% of the global market revenues for oxytocic pharmaceuticals will be
harvested from the sales of oxytocic pharmaceuticals originating from synthetic sources. By the end of
2026, an estimated US$ 148.9 million revenues will be emanated from the global sales of synthetic
oxytocic pharmaceuticals.
Future Market Insights’ published report on the global oxytocic pharmaceuticals market estimates that
the market, which is presently valued at US$ 62.2 million, will expand at an impressive 9.7% CAGR to
reach US$ 157.6 million value by 2026-end. In the report, titled “Oxytocic Pharmaceuticals Market:
Global Industry Analysis & Opportunity Assessment, 2016-2026,” Future Market Insights projects that
the global market for oxytocic pharmaceuticals will remain highly fragmented due to higher prevalence of
local players as opposed to multinationals and conglomerates. Nevertheless, global pharmaceutical
industry leaders such as Pfizer Inc., Novartis AG, Baxter Healthcare Corporation, and Teva Pharmaceutical
Industries Ltd. are also partaking in the global oxytocic pharmaceuticals market. Other leading
manufacturers of oxytocic pharmaceuticals include Biofutura Pharma SpA, Ferring BV, and Fresenius Kabi
AG.
©2015 Future Market Insights, All Rights Reserved
4
Europe Hospital Capacity Management Solutions Market
Global Oxytocic pharmaceuticals Market: Regional Analysis
The need for oxytocic pharmaceuticals in the world will always remain contingent to the rise in pregnancy
incidences and birth rate. Various parts of the world exhibit diverse birth rate, which incidentally drives
the growth of their oxytocic pharmaceuticals market, accordingly. In North America, oxytocic
pharmaceuticals are majorly used for postpartum haemorrhage, which is one of the most-prominent
indication among labouring women in the US and Canada. However, China is expected to remain the
largest market for oxytocic pharmaceuticals in the world. Considering the country’s exploding birth rate,
China’s oxytocic pharmaceuticals market will be valued over US$ 55 million by 2026-end, expanding at
9.8% CAGR. In 2016, Japan’s oxytocic pharmaceuticals revenues amounted to an estimated US$ 1.7
million, while the oxytocic pharmaceuticals market in Asia-Pacific excluding Japan & China (APEJC) region
has been estimated to account for nearly 20% of global revenues.
Global Oxytocic Pharmaceuticals Market: Research Highlights
 Licensing agreements for development of newer oxytocic pharmaceuticals is rampantly boosting the
global market revenues, profiting local players as well as industry leaders.
 Surging prevalence of labour induction procedures for child births will continue promoting the use of
oxytocic pharmaceuticals throughout the forecast period.
©2015 Future Market Insights, All Rights Reserved
5
Europe Hospital Capacity Management Solutions Market
 The global oxytocic pharmaceuticals revenues, however, are projected to witness an inhibited growth
on the account of rising preference to alternative drugs such as magnesium sulphate and misoprostol.
 India’s contribution to the APEJC oxytocic pharmaceuticals market is predicted to reach nearly 60% by
the end of 2026.
 More than 22,000 thousand units of oxytocic pharmaceuticals will be sold globally for treating labour
arrest over the forecast period.
 Hospitals will remain the largest end-user of oxytocic pharmaceuticals in the world, revenues from
which will expand beyond 12% CAGR.
 A majority of medical professionals in the world will recommend intravenous administration of
oxytocic pharmaceuticals, accounting for more than two-third of global market revenues by the end of
2026.
©2015 Future Market Insights, All Rights Reserved
6
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Oxytocic Pharmaceuticals Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
©2015 Future Market Insights, All Rights Reserved
7
Table of Content
4.5. Number of procedures by Indications per region (2015-2026)
4.6. Number of procedures by End User per region (2015-2026)
4.7. Number of cervical ripening procedures by region (2015)
4.8. Comparative drugs list other than Oxytocin
5. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Indication
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Indication Type
5.3. Y-o-Y Growth Projections By Indication Type
5.4. Market Value Forecast By Indication, 2016–2026
5.4.1. Abortion Induced Incomplete
5.4.2. Inevitable Abortion
5.4.3. Postpartum Hemorrhage
5.4.4. Labor Induction
5.4.5. Labor Arrest
5.5. Market Attractiveness By Indication
6. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By End User
6.1. Introduction
©2015 Future Market Insights, All Rights Reserved
8
Table of Content
6.2. Basis Point Share (BPS) Analysis By End User
6.3. Y-o-Y Growth Projections By End User
6.4. Market Value Forecast By End User, 2016–2026
6.4.1. Hospitals
6.4.2. Maternity Clinics
6.5. Market Attractiveness By End User
7. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Route of Administration
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Route of Administration
7.3. Y-o-Y Growth Projections By Route of Administration
7.4. Market Value Forecast By Route of Administration, 2016–2026
7.4.1. Intravenous Infusion/Injection
7.4.2. Intramuscular Injection
7.5. Market Attractiveness By Route of Administration
8. Global Oxytocic Pharmaceuticals Market Analysis and Forecasts, By Source of Origin
8.1. Introduction
8.2. Basis Point Share (BPS) Analysis By Source of Origin
8.3. Y-o-Y Growth Projections By Source of Origin
©2015 Future Market Insights, All Rights Reserved
9
Table of Content
8.4. Market Value Forecast By Source of Origin, 2016–2026
8.4.1. Synthetic Oxytocin Derivative
8.4.2. Natural Oxytocin (Animal Pituitary Extract)
8.5. Market Attractiveness By Source of Origin
©2015 Future Market Insights, All Rights Reserved
10
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For media queries, contact the press office at
[email protected]
For other queries contact:
Hari. T (Sr. Manager - Global Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
Thank You
Future Market Insights Global & Consulting Private Limited (FMI)
©2015 Future Market Insights, All Rights Reserved
11